Ancremonam
1-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-oxo-2-[[(3S,4R)-2-oxo-4-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-1-sulfoazetidin-3-yl]amino]ethylidene]amino]oxycyclopropane-1-carboxylic acid
Molecular Identity
Ancremonam
1-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-oxo-2-[[(3S,4R)-2-oxo-4-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-1-sulfoazetidin-3-yl]amino]ethylidene]amino]oxycyclopropane-1-carboxylic acid
PubChem CID: 118379834
2D Structure
Properties
C16H18N6O10S2
Molecular Formula
518.50
Molecular Weight
g/mol
518.0526
Exact Mass
Da
-0.7
XLogP
Drug-like (Lipinski: < 5)
268
TPSA
May have limited oral absorption
4
H-Bond Donors
14
H-Bond Acceptors
1040
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
AncremonamBOS-228Ancremonam [USAN]LYS-22829H7N9XI1BUNII-29H7N9XI1BANCREMONAM [INN]1-[(Z)-[1-(2-amino-1,3-thiazol-4-yl)-2-oxo-2-[[(3S,4R)-2-oxo-4-[(2-oxo-1,3-oxazolidin-3-yl)methyl]-1-sulfoazetidin-3-yl]amino]ethylidene]amino]oxycyclopropane-1-carboxylic acidAncremonam (USAN)1-((((Z)-1-(2-aminothiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxooxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxy)cyclopropane-1-carboxylic acid1-(((Z)-(1-(2-AMINO-1,3-THIAZOL-4-YL)-2-OXO-2-(((3S,4R)-2-OXO-4-((2-OXO-1,3-OXAZOLIDIN-3-YL)METHYL)-1-SULFOAZETIDIN-3-YL)AMINO)ETHYLIDENE)AMINO)OXY)CYCLOPROPANE-1-CARBOXYLIC ACID1-((Z)-(1-(2-amino-1,3-thiazol-4-yl)-2-oxo-2-(((3S,4R)-2-oxo-4-((2-oxo-1,3-oxazolidin-3-yl)methyl)-1-sulfoazetidin-3-yl)amino)ethylidene)amino)oxycyclopropane-1-carboxylic acidRefChem:1125861810051-96-7LYS228
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Ancremonam
Loading drug network...